$RVMD Cashflow Statement | Understand Stock

$RVMD

$183.90 -$3.09 (1.65%) Close

$RVMD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on disposal of fixed assets
Amortization of intangible assets
Stock-based compensation expense
Depreciation
Depreciation and amortization
Change in fair value of warrant liability and contingent earn-out shares
Non-cash interest expense on liabilities related to sale of future royalties
Net amortization of premium or discount on marketable securities
Amortization of operating lease right-of-use asset
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other current assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Operating lease liability
Deferred tax liability
Long-term deposits
Other noncurrent assets
Other noncurrent liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchases of marketable securities
Maturities of marketable securities
Sales of marketable securities
Purchases of property and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities
Cash, cash equivalents and restricted cash acquired in connection with EQRx Acquisition, net of transaction costs
Proceeds from the sale of future royalties, net of issuance costs
Proceeds from issuance of common stock, net of issuance costs
At The Market Equity Offering
Total proceeds from issuance of common stock, net of issuance costs

Proceeds from issuance of pre-funded warrants, net of transaction costs
Proceeds from issuance of common stock from at-the-market offering, net of transaction costs
Proceeds from issuance of common stock pursuant to stock option exercises
Proceeds from issuance of common stock related to employee stock purchase plan
Tax payment for common stock withheld in satisfaction of withholding tax requirements
Exercise of warrants
Payments of deferred offering costs
Net cash provided by financing activities
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning of year
Cash, cash equivalents and restricted cash - end of year
Reconciliation of cash, cash equivalents and restricted cash to consolidated balance sheets
Cash and cash equivalents
Restricted cash
Cash, cash equivalents and restricted cash - end of period
Supplemental disclosure of non-cash investing and financing activities
Issuance of common stock for EQRx acquisition
Fair value of net assets acquired in connection with EQRx Acquisition
EQRx acquisition transaction costs incurred but not paid
Vesting of early exercised options and restricted stock
Purchases of property and equipment in accounts payable and accrued expenses and other current liabilities
Advance payments for property and equipment
Right-of-use assets obtained in exchange for operating lease liabilities
Unpaid/deferred offering costs

Comments